So many of my elderly patients are now asking whether it’s worth it or not to treat early-stage lung cancer. “I have to die of something!”
But Dr. Walter Curran and colleagues from Emory University School of Medicine may now have a good answer to that important question. From 2003-2006, the National Cancer Data Base was analyzed for patients 70 years or older with early stage lung cancer who chose either a watch and wait approach or stereotactic radiosurgery, like that delivered by Cyber Knife. Their findings were reported in the August 2015 Journal of Cancer. The results were striking. Senior patients with early stage lung cancer treated with stereotactic radiosurgery had better survival than those patients who chose a watch and wait approach. Importantly, those patients were treated with stereotactic radiosurgery were no sicker initially than those who chose a watch and wait approach. And they fared much better afterwards.
Stereotactic Radiosurgery, Like that Delivered by Cyber Knife, May be the Solution to Those Fears
Stereotactic radiosurgery, like that delivered by Cyber Knife, has produced the same lung cancer control rates as surgery for early stage lung cancer patients, but with far fewer side effects. No incision. No pain. And no hospitalization. Cyber Knife is done on an outpatient basis. It’s now considered the standard of care for early stage lung cancer patients who are “medically inoperable” or too sick for surgery.
Recent results indicate that Cyber Knife stereotactic radiosurgery may be just as good as open surgery for medically operable patients, or those patients who are healthy enough for open surgery like lobectomy or video-assisted lobectomy. In a study in the June 2015 issue of the medical journal Lancet Oncology, Dr. Chang and coworkers reported that early-stage lung cancer patients treated with stereotactic radiosurgery had a 95% survival at 3 years versus only 79% for patients with surgery. And the complications with open are far more severe. My conclusion is that Cyber Knife radiosurgery may be just as good as open surgery even for young patients who are fit as a fiddle.
So What’s a Senior with Early Stage Lung Cancer To Do?
Dr. Jonathan Beitler of Johns Hopkins, commenting on this study, stated “I have to say that it seems to be the surgical community has resisted a large-scale randomized trial and from their point of view, who could blame them? On the other hand, are they looking out for the patient’s or for themselves?” That’s a sobering thought. While I’ll never comment on another person’s motives, I know that it can take a while before doctors change their practice habits. After all, it took over 50 years for surgeons to learn that a radical mastectomy just simply didn’t work. More is not always better. I do think it’s a good idea, may be even mandatory, for all early-stage lung cancer patients, young or old, to see a radiation oncologist experienced in Cyber Knife before undergoing the cold, hard steel sharp edge of the scalpel. It just may be in the patient’s best interest. Each and every week when I see early-stage lung cancer patients in consultation, I have to dispel a lot of myths about Cyber Knife. In this day of data driven decision making, it’s important to have the facts from a number of sources.
So if you have any questions, please feel free to call me, Dr. Ed Hughes, at 855-DAYTON1